The bear is growling angry right now on Wall Street, but that’s when savvy investors should be busy making shopping lists to pick up exposure
One group stands out as an interesting and potentially dramatically undervalued area of the market in the wake of the pandemic and its historical footprint:
Growth stocks have been on sale. For investors, the current bear market context could represent a defining opportunity for the years ahead. Rising interest rates,
One positive spin we can put on the “great growth stock bear market of 2022” – which, let’s face it, is what we are dealing
While you may not hear about it constantly anymore, the marketplace for non-fungible tokens continue to grow. A research piece out this week from JPMorgan
The electric grid is probably the most important piece of infrastructure we have. At base, it’s a network that connects nearly 10,000 power producing units
Planet 13 Holdings Inc (OTCMKTS:PLNHF) shares have been taking a beating over the past 10 months in a steady downward trend. Management hopes to change
Just when we started to think it was over, Omicron popped up and reminded us that this thing is a whole lot more complex than
2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks
Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The
A few years ago, Bitcoin was an afterthought (or a non-thought) to most on Wall Street. It was so poorly understood that plenty of traders
We love a good pharma story that can cook on a small float. That’s why we are putting NTRB Nutriband Inc. (OTCMKTS: NTRB) in front of
Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) issued its financial report for the third quarter closed September 30, 2017. The firm’s Q3 2017 revenue and GAAP earnings/diluted ADS
Geron Corporation (NASDAQ:GERN) reported that the U.S. FDA has granted Fast Track designation to imetelstat for the prospective treatment of adult people with transfusion-dependent anemia
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported new findings showcasing the frustration of patients suffering from IBS-C and the viewpoint of healthcare providers who cure these patients.
The bear is growling angry right now on Wall Street, but that’s when savvy investors should be busy making shopping lists to pick up exposure
One group stands out as an interesting and potentially dramatically undervalued area of the market in the wake of the pandemic and its historical footprint:
Growth stocks have been on sale. For investors, the current bear market context could represent a defining opportunity for the years ahead. Rising interest rates,
One positive spin we can put on the “great growth stock bear market of 2022” – which, let’s face it, is what we are dealing
While you may not hear about it constantly anymore, the marketplace for non-fungible tokens continue to grow. A research piece out this week from JPMorgan
The electric grid is probably the most important piece of infrastructure we have. At base, it’s a network that connects nearly 10,000 power producing units
Planet 13 Holdings Inc (OTCMKTS:PLNHF) shares have been taking a beating over the past 10 months in a steady downward trend. Management hopes to change
Just when we started to think it was over, Omicron popped up and reminded us that this thing is a whole lot more complex than
2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks
Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The
A few years ago, Bitcoin was an afterthought (or a non-thought) to most on Wall Street. It was so poorly understood that plenty of traders
We love a good pharma story that can cook on a small float. That’s why we are putting NTRB Nutriband Inc. (OTCMKTS: NTRB) in front of
Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) issued its financial report for the third quarter closed September 30, 2017. The firm’s Q3 2017 revenue and GAAP earnings/diluted ADS
Geron Corporation (NASDAQ:GERN) reported that the U.S. FDA has granted Fast Track designation to imetelstat for the prospective treatment of adult people with transfusion-dependent anemia
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported new findings showcasing the frustration of patients suffering from IBS-C and the viewpoint of healthcare providers who cure these patients.
